CS logo
small CS logo
Donald J. Garcia, Jr., MD, PA

Austin, Texas, United States
Psychiatrist in Travis County, Texas
7900 Farm to Market Road 1826 Health Plaza 2, Suite 205, Austin, TX 78737

About Donald J. Garcia, Jr., MD, PA


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Naurex, Inc, an affiliate of Allergan plc
6
Allergan
2
Biohaven Pharmaceuticals, Inc.
1
Concert Pharmaceuticals
1
Gate Neurosciences, Inc
1
Pfizer
1
Sirtsei Pharmaceuticals, Inc.
1
Total Rows: 7

Clinical Trials at Donald J. Garcia, Jr., MD, PA


During the past decade, Donald J. Garcia, Jr., MD, PA conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years221155222211000000115511Started TrialsCompleted Trails2016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
2016-10-15
2018-11-08
Completed
465
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
2016-11-13
2019-02-22
Completed
1,304
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
2017-02-03
2018-12-06
Completed
617
Study of Rapastinel as Monotherapy in Patients With MDD
2018-06-15
2019-07-08
Terminated
439
AGN-241751 in the Treatment of Major Depressive Disorder
2018-06-13
2019-08-21
Completed
251
Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD)
2018-08-02
2019-07-11
Terminated
363
Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)
2018-08-23
2019-07-03
Terminated
230
12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine
2018-12-14
2020-06-19
Completed
910

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Donald J. Garcia, Jr., MD, PA" #1 sponsor was "Naurex, Inc, an affiliate of Allergan plc" with 6 trials, followed by "Allergan" with 2 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 1 trials sponsored, "Concert Pharmaceuticals" with 1 trials sponsored and "Gate Neurosciences, Inc" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Donald J. Garcia, Jr., MD, PA" #1 collaborator was "Cognitive Research Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNaurex, Inc, an affiliateof Allergan plc: 6Naurex, Inc, an affiliateof Allergan plc: 6Allergan: 2Allergan: 2BiohavenPharmaceuticals, Inc.: 1BiohavenPharmaceuticals, Inc.: 1Concert Pharmaceuticals: 1Concert Pharmaceuticals: 1Gate Neurosciences, Inc: 1Gate Neurosciences, Inc: 1Pfizer: 1Pfizer: 1Sirtsei Pharmaceuticals, Inc.: 1Sirtsei Pharmaceuticals, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsCognitive ResearchCorporation: 1Cognitive ResearchCorporation: 1

Clinical Trials Conditions at Donald J. Garcia, Jr., MD, PA


According to Clinical.Site data, the most researched conditions in "Donald J. Garcia, Jr., MD, PA" are "Depressive Disorder, Major" (7 trials), "Episodic Migraine" (2 trials), "Major Depressive Disorder" (1 trials), "Migraine" (1 trials) and "Obsessive-Compulsive Disorder" (1 trials). Many other conditions were trialed in "Donald J. Garcia, Jr., MD, PA" in a lesser frequency.

Clinical Trials Intervention Types at Donald J. Garcia, Jr., MD, PA


Most popular intervention types in "Donald J. Garcia, Jr., MD, PA" are "Drug" (13 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Rapastinel" (6 trials), "Atogepant" (2 trials), "AGN-241751" (1 trials) and "CTP-692" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Donald J. Garcia, Jr., MD, PA


The vast majority of trials in "Donald J. Garcia, Jr., MD, PA" are 13 trials for "All" genders.

Clinical Trials Status at Donald J. Garcia, Jr., MD, PA


Currently, there are NaN active trials in "Donald J. Garcia, Jr., MD, PA". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Donald J. Garcia, Jr., MD, PA, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Donald J. Garcia, Jr., MD, PA, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 10Phase 3: 10Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Terminated: 3Terminated: 3Recruiting: 1Recruiting: 1